Industrial Biotechnology Award

1

• Industrial Biotechnology Award
• This award is to honor organizations or
  individuals for their achievements in the
  commercialization of novel processes exploiting
  biochemical technology. The inaugural award was
  made at the Fall, 1998 meeting in Boston.
• The award
• (1) will be made to companies, teams,
  organizations or individuals
• (2) will be in the form of a plaque there will
  be no cash award
• (3) will require/invite recipients to give a talk
  at the ACS national meeting. The talk will be as
  open as possible. Travel expenses are expected to
  be born by the recipient
• (4) will be for commercial bioprocess technology
  and will favor processes brought to commercial
  practice within the past 5 to 10 years
• (5) will honor "processes" broadly defined to
  include fully integrated processes to produce a
  biological product, technology that underlies or
  enables multiple processes, or processes that
  solve environmental problems (e.g.
  bioremediation).
• The award process
• (1) will allow both self-nominations and
  nominations by others
• (2) will require submission of application
  material by a specified date in advance of the
  meeting
• (3) will automatically reconsider prior
  unsuccessful nominations in the two rounds
  following the initial submission. Further
  consideration will require renomination
• (4) will consider as selection criteria the
  innovativeness of the process, its commercial
  and/or societal impact, and the contribution of
  the process to advancing the state of the art in
  bioprocess technology as evidenced by patents,
  books, journal articles, or other forms of public
  disclosure
• (5) will involve a review process by a selection
  committee.

Nomination for Industrial Biotechnology
Award Deadline February 28, 2007 Send
Nomination Package to the BIOT Awards
Chair Weichang Zhou, Ph.D. PDL BioPharma, Inc.
34801 Campus Drive Fremont, CA 94555 Tel
[phone] WEICHANG.ZHOU_at_PDL.COM (Modify
spacing to fit your responses). Basic Data 1.
Proposed Title for Presentation at ACS National
Meeting 2. Name of Group/Company Responsible
for Process 3. List all individuals of the
team who contributed to design and development of
process 4. Name, address, phone number, and
e-mail of contact person 5. Name of Presenter
(if available) 6. Please provide three
references (from outside your organization) who
can comment on the importance and innovativeness
of the bioprocess technology. References should
be sent directly to the address below or provided
with the application in sealed and signed
envelopes. 7. Proposed Citation (not more than
25 words that accurately reflect specific
accomplishments) Nomination Narrative (Items
8-13 Maximum 4 pages of text plus one page for
figures and charts) 8. Describe the process. A
flow diagram or pictorial representation may be
included. 9. When was the process commercialized?
(i.e., when did the product of the process first
become available or when was the process first
implemented on a large scale?) 10. What makes the
process innovative? 11. Why is the process
important? What is its commercial impact? 12. How
has the development of this process contributed
to advancing the state of the art in bioprocess
technology? 13. List patents, books, or articles
that provide public disclosure and support the
broad development of bioprocess technology. You
may attach copies of these items as appendices.